✦ LIBER ✦

Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis

✍ Scribed by Cholon, D. M.; Quinney, N. L.; Fulcher, M. L.; Esther, C. R.; Das, J.; Dokholyan, N. V.; Randell, S. H.; Boucher, R. C.; Gentzsch, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ivacaftor in Subjects With Cystic Fibros

✍ Flume, Patrick A. 📂 Article 📅 2012 🏛 American College of Chest Physicians 🌐 English ⚖ 834 KB

A CFTR corrector (lumacaftor) and a CFTR

✍ Boyle, Michael P; Bell, Scott C; Konstan, Michael W; McColley, Susanna A; Rowe, 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 423 KB

WS9.9 The CFTR potentiator ivacaftor cor

✍ K. Pohl; E.P. Reeves; N.G. McElvaney 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

WS1.1 The effect of ivacaftor, a CFTR po

✍ De Boeck, K.; Munck, A.; Walker, S.; Faro, A.; Hiatt, P.; Chan, J.; Gilmartin, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Frequency of the F508 deletion in the CF

✍ Joachim Hundrieser; Silvia Bremer; Frank Peinemann; Manfred Stuhrmann; Nicola Ho 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 188 KB

Clinical evaluation of VX-809, a novel i

✍ J.P. Clancy; G. Spencer-Green 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB